GILD GILEAD SCIENCES, INC.: institutional ownership and insider trading
2,498 funds reported holding $160B of GILEAD SCIENCES, INC. in their latest 13F filings; in Q2 2026 funds net bought $5.98B, with 126 new positions and 164 funds selling out; over the last 12 months insiders bought $0 and sold $87.9M on the open market; over its last four quarters it reported revenue of $30.5B and net income of −$3.24B.
GILD revenue and earnings
- Quarter ended Jun 30, 2026: revenue $7.80B, net income −$10.5B, EPS -8.45
- Quarter ended Mar 31, 2026: revenue $6.96B, net income $2.02B, EPS 1.61
- Quarter ended Dec 31, 2025: revenue $7.93B, net income $2.18B, EPS 1.75
- Quarter ended Sep 30, 2025: revenue $7.77B, net income $3.05B, EPS 2.43
Famous investors holding GILD
- Renaissance Technologies (Renaissance Technologies): $280M, 0.4% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $314M, 0.2% of the portfolio
- Ray Dalio (Bridgewater Associates): $36.7M, 0.2% of the portfolio
- Izzy Englander (Millennium Management): $275M, 0.1% of the portfolio
- Ken Griffin (Citadel Advisors): $704M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $51.7M, 0.0% of the portfolio
Largest institutional holders of GILD
- BlackRock, Inc. (BLK) — $15.4B
- VANGUARD GROUP INC — $14.9B
- VANGUARD CAPITAL MANAGEMENT LLC — $10.2B
- FMR LLC — $8.45B
- STATE STREET CORP (STT, STT-PG) — $7.73B
- Capital World Investors — $5.18B
- Invesco Ltd. (IVZ) — $5.03B
- VANGUARD PORTFOLIO MANAGEMENT LLC — $4.46B
- GEODE CAPITAL MANAGEMENT, LLC — $3.80B
- PRICE T ROWE ASSOCIATES INC /MD/ — $3.79B
Recent GILD insider trades
- Oct 15, 2026: Dickinson Andrew D sold 3,000 shares ($469K)
- Oct 15, 2026: Mercier Johanna sold 3,000 shares ($469K)
- Oct 1, 2026: O'Day Daniel Patrick sold 15,000 shares ($2.22M)
- Sep 15, 2026: Dickinson Andrew D sold 3,000 shares ($436K)
Members of Congress trading GILD
- May 6, 2026: Jared Moskowitz bought $1.00K–$15.0K
- May 6, 2026: Jared Moskowitz bought $1.00K–$15.0K
- Jan 27, 2026: Josh Gottheimer bought $1.00K–$15.0K
- Sep 23, 2025: Val T. Hoyle sold $1.00K–$15.0K
- Jun 6, 2025: Marjorie Taylor Greene bought $1.00K–$15.0K
- May 14, 2025: Josh Gottheimer sold $1.00K–$15.0K
- May 12, 2025: Jefferson Shreve sold $15.0K–$50.0K
- May 5, 2025: Marjorie Taylor Greene bought $1.00K–$15.0K
- May 5, 2025: Marjorie Taylor Greene bought $1.00K–$15.0K
- Mar 31, 2025: Jefferson Shreve bought $15.0K–$50.0K
5%+ owners
- Vanguard Capital Management: 7.5% (Schedule 13G, filed Apr 29, 2026)
Who owns the most GILD stock?
The largest institutional holders of GILEAD SCIENCES, INC. in the latest 13F filings are BlackRock, Inc. (BLK) ($15.4B), VANGUARD GROUP INC ($14.9B), VANGUARD CAPITAL MANAGEMENT LLC ($10.2B).
Are insiders buying or selling GILD?
Over the last 12 months insiders bought $0 and sold $87.9M of GILEAD SCIENCES, INC. stock on the open market (SEC Form 4).
Which famous investors own GILD?
Renaissance Technologies, D. E. Shaw, Ray Dalio, Izzy Englander, Ken Griffin.
What was GILD's revenue last quarter?
GILEAD SCIENCES, INC. reported revenue of $7.80B for the quarter ended June 30, 2026, with net income of −$10.5B.
Which ETFs hold GILD?
850 ETFs and mutual funds hold it among their top 100 positions, including VTI, VOO, QQQ, DODGX.